Patients with chronic kidney disease, cardiovascular diseases, and those with obesity related complications such as moderate to severe obstructive sleep apnea (OSA) should not use microdoses of GLP-1 medications
Increases will go into effect in July, according to the insurance agency, which covers 150,000 government workers, 56,000 retirees and their dependents
Luthi, H
Many people take GLP-1 medications for 12 months or longer
Practice stress-reducing techniques such as mindfulness, meditation, or yoga
GLP-1 side effects should be discussed with a doctor when nausea, constipation, vomiting, reflux, fatigue, dizziness, abdominal pain, dehydration, or poor intake interferes with daily life, prevents the patient from eating enough protein or drinking enough fluid, worsens after a dose increase, persists for more than a short adjustment period, or feels severe or unusual